Examination of the hallucinogen 2,5-dimethoxy-4-methylamphetamine
G F Phillips, R J Mesley
Journal of Pharmacy and Pharmacology 1969 DOI: 10.1111/j.2042-7158.1969.tb08122.x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Laboratory study Peer reviewed |
|---|---|
| Key points | The hallucinogenic drug STP is 2,5-dimethoxy-4-methylamphetamine (DOM), which is up to 50 times more potent than mescaline in animal behavioral tests. |
Abstract
Abstract Physical characteristics are reported for a tablet form of a new hallucinogenic drug previously circulating in the USA under the name “STP”. High resolution mass, nmr, ultraviolet and infrared spectrometric evidence, which identify the extracted base as 2,5-dimethoxy-4-methylamphetamine, and its chromatographic behaviour, are compared with the experimental compound “DOM”. Polymorphic modifications exhibiting distinct solid phase infrared spectra have been studied by X-ray diffraction and by differential calorimetry. Animal behavioural tests indicate that the psychotomimetic activity of the base is comparable with mescaline but up to 50 times more potent.
Citations in the library
Cited by 3
- The new drug phenomenon Drug Testing and Analysis July 1, 2014
- A brief history of ‘new psychoactive substances’ Drug Testing and Analysis July 1, 2011
- Identification of seven psychedelic 2,5-dimethoxy-phenylethyl-amine-based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy. Magnetic resonance in chemistry : MRC February 1, 2023